Liver transplantation for hereditary tyrosinemia type I: Analysis of the UNOS database

Ronen Arnon, Rachel Annunziato, Tamir Miloh, Melissa P. Wasserstein, Hiroshi Sogawa, Monique Wilson, Frederick Suchy, Nanda Kerkar

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Patients with HT-1 can develop progressive liver disease and have a high incidence of HCC. LT is indicated in patients with fulminant liver failure, HCC or decompensated chronic liver disease refractory to NTBC. To determine the need for LT and outcomes after LT in children with HT-1. Children with HT-1 who had LT between 10/1987 and 5/2008 were identified from the UNOS database. Of 11 467 children in the UNOS database, 125 (1.1%) required LT secondary to HT-1. Mean age at LT was two and half yr (s.d. ± 3.6 yr). Mean age at LT during the first 10 yr of the study (1.82, s.d. ± 2.86 yr) was significantly lower than in the last decade (3.70, s.d. ± 4.42 yr), p = 0.01. Nearly half of the patients (58, 46.4%) were transplanted between 1988 and 1992. Overall, one- and five-yr patient survival was 90.4% and 90.4%, respectively. LT is a valuable option for children with HT-1 with fulminant liver failure or when medical treatment fails. The rate of LT for children with HT-1 has decreased and age at transplant increased over the last decade most probably reflecting the effect of early diagnosis and treatment with NTBC.

Original languageEnglish (US)
Pages (from-to)400-405
Number of pages6
JournalPediatric Transplantation
Volume15
Issue number4
DOIs
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Tyrosinemias
Liver Transplantation
Databases
Acute Liver Failure
Liver Diseases
Early Diagnosis
Chronic Disease
Transplants
Survival
Incidence
Therapeutics

Keywords

  • complications of liver transplantation
  • congenital liver disease
  • graft survival
  • liver transplantation
  • pediatric transplantation
  • tyrosinemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Liver transplantation for hereditary tyrosinemia type I : Analysis of the UNOS database. / Arnon, Ronen; Annunziato, Rachel; Miloh, Tamir; Wasserstein, Melissa P.; Sogawa, Hiroshi; Wilson, Monique; Suchy, Frederick; Kerkar, Nanda.

In: Pediatric Transplantation, Vol. 15, No. 4, 06.2011, p. 400-405.

Research output: Contribution to journalArticle

Arnon, R, Annunziato, R, Miloh, T, Wasserstein, MP, Sogawa, H, Wilson, M, Suchy, F & Kerkar, N 2011, 'Liver transplantation for hereditary tyrosinemia type I: Analysis of the UNOS database', Pediatric Transplantation, vol. 15, no. 4, pp. 400-405. https://doi.org/10.1111/j.1399-3046.2011.01497.x
Arnon, Ronen ; Annunziato, Rachel ; Miloh, Tamir ; Wasserstein, Melissa P. ; Sogawa, Hiroshi ; Wilson, Monique ; Suchy, Frederick ; Kerkar, Nanda. / Liver transplantation for hereditary tyrosinemia type I : Analysis of the UNOS database. In: Pediatric Transplantation. 2011 ; Vol. 15, No. 4. pp. 400-405.
@article{0cbac37a8388474487b8924296bc1c14,
title = "Liver transplantation for hereditary tyrosinemia type I: Analysis of the UNOS database",
abstract = "Patients with HT-1 can develop progressive liver disease and have a high incidence of HCC. LT is indicated in patients with fulminant liver failure, HCC or decompensated chronic liver disease refractory to NTBC. To determine the need for LT and outcomes after LT in children with HT-1. Children with HT-1 who had LT between 10/1987 and 5/2008 were identified from the UNOS database. Of 11 467 children in the UNOS database, 125 (1.1{\%}) required LT secondary to HT-1. Mean age at LT was two and half yr (s.d. ± 3.6 yr). Mean age at LT during the first 10 yr of the study (1.82, s.d. ± 2.86 yr) was significantly lower than in the last decade (3.70, s.d. ± 4.42 yr), p = 0.01. Nearly half of the patients (58, 46.4{\%}) were transplanted between 1988 and 1992. Overall, one- and five-yr patient survival was 90.4{\%} and 90.4{\%}, respectively. LT is a valuable option for children with HT-1 with fulminant liver failure or when medical treatment fails. The rate of LT for children with HT-1 has decreased and age at transplant increased over the last decade most probably reflecting the effect of early diagnosis and treatment with NTBC.",
keywords = "complications of liver transplantation, congenital liver disease, graft survival, liver transplantation, pediatric transplantation, tyrosinemia",
author = "Ronen Arnon and Rachel Annunziato and Tamir Miloh and Wasserstein, {Melissa P.} and Hiroshi Sogawa and Monique Wilson and Frederick Suchy and Nanda Kerkar",
year = "2011",
month = "6",
doi = "10.1111/j.1399-3046.2011.01497.x",
language = "English (US)",
volume = "15",
pages = "400--405",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Liver transplantation for hereditary tyrosinemia type I

T2 - Analysis of the UNOS database

AU - Arnon, Ronen

AU - Annunziato, Rachel

AU - Miloh, Tamir

AU - Wasserstein, Melissa P.

AU - Sogawa, Hiroshi

AU - Wilson, Monique

AU - Suchy, Frederick

AU - Kerkar, Nanda

PY - 2011/6

Y1 - 2011/6

N2 - Patients with HT-1 can develop progressive liver disease and have a high incidence of HCC. LT is indicated in patients with fulminant liver failure, HCC or decompensated chronic liver disease refractory to NTBC. To determine the need for LT and outcomes after LT in children with HT-1. Children with HT-1 who had LT between 10/1987 and 5/2008 were identified from the UNOS database. Of 11 467 children in the UNOS database, 125 (1.1%) required LT secondary to HT-1. Mean age at LT was two and half yr (s.d. ± 3.6 yr). Mean age at LT during the first 10 yr of the study (1.82, s.d. ± 2.86 yr) was significantly lower than in the last decade (3.70, s.d. ± 4.42 yr), p = 0.01. Nearly half of the patients (58, 46.4%) were transplanted between 1988 and 1992. Overall, one- and five-yr patient survival was 90.4% and 90.4%, respectively. LT is a valuable option for children with HT-1 with fulminant liver failure or when medical treatment fails. The rate of LT for children with HT-1 has decreased and age at transplant increased over the last decade most probably reflecting the effect of early diagnosis and treatment with NTBC.

AB - Patients with HT-1 can develop progressive liver disease and have a high incidence of HCC. LT is indicated in patients with fulminant liver failure, HCC or decompensated chronic liver disease refractory to NTBC. To determine the need for LT and outcomes after LT in children with HT-1. Children with HT-1 who had LT between 10/1987 and 5/2008 were identified from the UNOS database. Of 11 467 children in the UNOS database, 125 (1.1%) required LT secondary to HT-1. Mean age at LT was two and half yr (s.d. ± 3.6 yr). Mean age at LT during the first 10 yr of the study (1.82, s.d. ± 2.86 yr) was significantly lower than in the last decade (3.70, s.d. ± 4.42 yr), p = 0.01. Nearly half of the patients (58, 46.4%) were transplanted between 1988 and 1992. Overall, one- and five-yr patient survival was 90.4% and 90.4%, respectively. LT is a valuable option for children with HT-1 with fulminant liver failure or when medical treatment fails. The rate of LT for children with HT-1 has decreased and age at transplant increased over the last decade most probably reflecting the effect of early diagnosis and treatment with NTBC.

KW - complications of liver transplantation

KW - congenital liver disease

KW - graft survival

KW - liver transplantation

KW - pediatric transplantation

KW - tyrosinemia

UR - http://www.scopus.com/inward/record.url?scp=79957480038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957480038&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2011.01497.x

DO - 10.1111/j.1399-3046.2011.01497.x

M3 - Article

C2 - 21504522

AN - SCOPUS:79957480038

VL - 15

SP - 400

EP - 405

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 4

ER -